Lack of patient adherence to prescribed medications poses a tremendous challenge to the global healthcare community. In the US alone, avoidable medical spending was estimated at $300 billion in 2009, and in Europe, a 2008 statistic of the PGEU European association for community pharmacists mentions 194.000 deaths a year due to non-adherence. Bridging the adherence gap is a ‘must do’ for pharmaceutical companies to protect their top line while transforming themselves from product to patient-centric organizations.

This is the result of a Capgemini Consulting research across Europe and the United States. The aim of the research was to understand the root causes of non-adherence, how the industry has addressed non-adherence in the past and what an innovative approach should look like.

More information on the Vision & Reality report.